Although we found good correlation of manual and software supported semi-quantitative scoring for the membranous marker CD147, further studies using additional biomarkers are warranted to prove reliability of software-based automated scoring for ccRCC. This evidence concerns the gene BSG and nonpapillary renal cell carcinoma.